Equasens Société anonyme – LSE:0R9T.L
Equasens Société anonyme stock price today
Equasens Société anonyme stock price monthly change
Equasens Société anonyme stock price quarterly change
Equasens Société anonyme stock price yearly change
Equasens Société anonyme key metrics
Market Cap | 656.11M |
Enterprise value | 691.92M |
P/E | 15.92 |
EV/Sales | 3.21 |
EV/EBITDA | 12.06 |
Price/Sales | 3.09 |
Price/Book | 3.16 |
PEG ratio | 0.49 |
EPS | 4.68 |
Revenue | 329.68M |
EBITDA | 103.02M |
Income | 70.57M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 19.64% |
Oper. margin | 22.37% |
Gross margin | 29.64% |
EBIT margin | 22.37% |
EBITDA margin | 31.25% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeEquasens Société anonyme stock price history
Equasens Société anonyme stock forecast
Equasens Société anonyme financial statements
| Mar 2023 | 56.31M | 10.99M | 19.52% |
|---|---|---|---|
| Jun 2023 | 112.62M | 21.98M | 19.52% |
| Sep 2023 | 53.58M | 12.53M | 23.39% |
| Dec 2023 | 107.16M | 25.06M | 23.39% |
| 2027 | 238.12M | 60.26K | 0.03% |
|---|
Analysts Price target
Financials & Ratios estimates
| Payout ratio | 44.47% |
|---|
| 2019 | 1.4% |
|---|---|
| 2020 | 0.81% |
| 2021 | 1.01% |
| 2022 | 1.4% |
| 2023 | 1.88% |
| Mar 2023 | 379208000 | 177.07M | 46.7% |
|---|---|---|---|
| Jun 2023 | 379208000 | 177.07M | 46.69% |
| Sep 2023 | 394045000 | 166.41M | 42.23% |
| Dec 2023 | 394045000 | 166.41M | 42.23% |
| Mar 2023 | 26.33M | -5.82M | -24.79M |
|---|---|---|---|
| Jun 2023 | 54.58M | -11.65M | -51.50M |
| Sep 2023 | 2.52M | -17.50M | 16.75M |
| Dec 2023 | 7.00M | -38.88M | 35.41M |
Equasens Société anonyme alternative data
| Aug 2023 | 1,200 |
|---|---|
| Sep 2023 | 1,200 |
| Oct 2023 | 1,221 |
| Nov 2023 | 1,200 |
| Dec 2023 | 1,200 |
| Jan 2024 | 1,200 |
| Feb 2024 | 1,200 |
| Mar 2024 | 1,200 |
| Apr 2024 | 1,200 |
| May 2024 | 1,200 |
| Jun 2024 | 1,200 |
| Jul 2024 | 1,271 |
Equasens Société anonyme other data
| Insider | Compensation |
|---|---|
Mr. Dominique Pautrat (1965) Chief Executive Officer, MD & Director | $269,250 |
Mr. Thierry Chapusot (1959) Founder & Chairman | $24,000 |
Mr. Jean-Yves Samson Chief Admin. & Financial Officer | |
Ms. Sabrina Gharbi HR Director | |
Mr. Grégoire De Rotalier Deputy MD, Director of Healthcare, Medical & Social Software Division and Director |
-
What's the price of Equasens Société anonyme stock today?
One share of Equasens Société anonyme stock can currently be purchased for approximately $94.68.
-
When is Equasens Société anonyme's next earnings date?
Unfortunately, Equasens Société anonyme's (0R9T.L) next earnings date is currently unknown.
-
Does Equasens Société anonyme pay dividends?
Yes, Equasens Société anonyme pays dividends and its trailing 12-month yield is 2.82% with 44% payout ratio. The last Equasens Société anonyme stock dividend of $0.9 was paid on 3 Jul 2020.
-
How much money does Equasens Société anonyme make?
Equasens Société anonyme has a market capitalization of 656.11M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 2.67% to 219.79M US dollars.
-
What is Equasens Société anonyme's stock symbol?
Equasens Société anonyme is traded on the LSE under the ticker symbol "0R9T.L".
-
What is Equasens Société anonyme's primary industry?
Company operates in the Healthcare sector and Medical - Equipment & Services industry.
-
How do i buy shares of Equasens Société anonyme?
Shares of Equasens Société anonyme can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Equasens Société anonyme's key executives?
Equasens Société anonyme's management team includes the following people:
- Mr. Dominique Pautrat Chief Executive Officer, MD & Director(age: 60, pay: $269,250)
- Mr. Thierry Chapusot Founder & Chairman(age: 66, pay: $24,000)
- Mr. Jean-Yves Samson Chief Admin. & Financial Officer
- Ms. Sabrina Gharbi HR Director
- Mr. Grégoire De Rotalier Deputy MD, Director of Healthcare, Medical & Social Software Division and Director
-
Is Equasens Société anonyme founder-led company?
Yes, Equasens Société anonyme is a company led by its founder Mr. Thierry Chapusot.
-
How many employees does Equasens Société anonyme have?
As Jul 2024, Equasens Société anonyme employs 1,271 workers, which is 6% more then previous month and 6% more then previous quarter.
-
When Equasens Société anonyme went public?
Equasens Société anonyme is publicly traded company for more then 11 years since IPO on 3 Jan 2014.
-
What is Equasens Société anonyme's official website?
The official website for Equasens Société anonyme is pharmagest.com.
-
How can i contact Equasens Société anonyme?
Equasens Société anonyme can be reached via phone at +33 3 83 15 95 95.
Equasens Société anonyme company profile:
Equasens Société anonyme
pharmagest.comLSE
1,271
Medical - Equipment & Services
Healthcare
Equasens Société anonyme provides various IT solutions for the healthcare sector in Europe. It offers LGPI global services and OffiCentral solutions for managing pharmacies and their networks; OffiMSS, OffiSecure, OffiProtect, OffiPass, OffiSeen, OffiCash, Offizzy, and OffiLocker solutions for pharmacists' business processes; and solutions for energizing the customer relationship with pharmacists comprising OffiTag, OffiTouch, OffiMédia, OffiConnect, automation systems, and customer loyalty programs. The company also provides My Pilot, an analytics and management tool; OffiLearning, an e-learning tool; and solutions for patient support and advice, such as compliance monitoring software, Multimeds, Automeds, and OffiTéléconsult, as well as pharmaceutical record and shared medical record services. In addition, it offers a ULTIMATE, a system combining optimized pharmacy management and improved patient support; FARMACLICK, a protocol for communications between pharmacies and wholesalers-distributors; DIFARM, a solution for wholesalers-distributors; PHARE, a retail management tool; SOPHIA, a pharmacy management application; OffiMédia POS display; eNephro to enhance the care of chronic renal failure patients; and TPE Pilot, a web-based application that simplifies the management and sharing of patient education programs. Further, the company provides NOVIACARE; CARELIB Domicile; CARELIB EHPAD; KAPELSE solutions; TITAN solutions; ANTHADINE software and MOBISOINS mobile tool; MICROSOINS, an in-home nursing care solution; and LOGICLIC. Additionally, it offers AXIGATE solutions to manage the entire patient care pathway; CHORUS platform; medical telesecretarial services for healthcare professionals; and equipment lease financing solutions. The company was incorporated in 1996 and is based in Villers-les-Nancy, France. Equasens Société anonyme is a subsidiary of Marque Verte Sante.
Villers-lès-Nancy, 54601
:
ISIN: FR0012882389
:
